Biacore Launches Biacore X100 for Protein Interaction Analysis

Biacore, now part of GE Healthcare, has announced the launch of Biacore™ X100, a ready to run system for label-free protein interaction analysis, designed for multi-project life science research laboratories.

During more than 15 years, data from Biacore systems have been cited in over 4500 scientific publications, so the technology is well-proven. However, many researchers expressed the need for a general purpose system which would be readily accessible for multiple users.

Biacore X100 fulfils this need. Using software tools to incorporate years of experience and application expertise, this system leads the user from preparation to result, within a day.

Biacore systems can enable scientists to draw confident conclusions based on characterization of how proteins interact with other molecules. A single instrument determines affinity and rate constants, binding specificity, concentration and thermodynamic parameters of the interaction.

Researchers are able to deepen their understanding of molecular mechanisms and interaction pathways, determine protein functionality and elucidate disease mechanisms.

Biacore X100 complements a range of systems that now can enable scientists to choose the solution best suited to their application requirements, from basic research through drug discovery and development to quality control.